| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Integrative Physiology |
From the Department of Anesthesia and Critical Care (F.I., W.M.Z., A.S., R.U., R.J.), the Cardiovascular Research Center (F.I., K.D.B.), and the Center for Immunology and Inflammatory Diseases (A.M.T.), Massachusetts General Hospital, Harvard Medical School, Boston, Mass, and Division of Pulmonary and Critical Care Medicine (K.C.), University of North Carolina, Chapel Hill, NC.
Correspondence to Fumito Ichinose, MD, Department of Anesthesia and Critical Care, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114. E-mail ichinose{at}etherdome.mgh.harvard.edu
AbstractSepsis and endotoxemia impair hypoxic pulmonary vasoconstriction (HPV), thereby reducing systemic oxygenation. To assess the role of leukotrienes (LTs) in the attenuation of HPV during endotoxemia, the increase in left lung pulmonary vascular resistance (LPVR) before and during left mainstem bronchus occlusion (LMBO) was measured in mice with and without a deletion of the gene encoding 5-lipoxygenase (5-LO). LMBO increased the LPVR equally in saline-challenged wild-type and 5-LOdeficient mice (96±20% and 94±19%, respectively). Twenty-two hours after challenge with Escherichia coli endotoxin, the ability of LMBO to increase LPVR was markedly impaired in wild-type mice (27±7%; P<0.05) but not in 5-LOdeficient mice (72±9%) or in wild-type mice pretreated with MK886, an inhibitor of 5-LO activity (76±10%). Compared with wild-type mice, endotoxin-induced disruption of lung structures and inflammatory cell influx in the lung were markedly attenuated in 5-LOdeficient mice. Administration of MK571, a selective cysteinyl LT1 receptor antagonist, 1 hour before endotoxin challenge preserved HPV and attenuated pulmonary injury in wild-type mice but did not prevent the endotoxin-induced increase in pulmonary myeloperoxidase activity. Taken together, these findings demonstrate that a 5-LO product, most likely a cysteinyl LT, contributes to the attenuation of HPV and to pulmonary injury after challenge with endotoxin.
Key Words: cysteinyl leukotrienes pulmonary injury left mainstem bronchus occlusion
This article has been cited by other articles:
![]() |
A. R. Carvalho, P. M. Spieth, P. Pelosi, A. Beda, A. J. Lopes, B. Neykova, A. R. Heller, T. Koch, and M. Gama de Abreu Pressure Support Ventilation and Biphasic Positive Airway Pressure Improve Oxygenation by Redistribution of Pulmonary Blood Flow Anesth. Analg., September 1, 2009; 109(3): 856 - 865. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Frank and M. A. Matthay Leukotrienes in Acute Lung Injury: A Potential Therapeutic Target? Am. J. Respir. Crit. Care Med., August 1, 2005; 172(3): 261 - 262. [Full Text] [PDF] |
||||
![]() |
P. Caironi, F. Ichinose, R. Liu, R. C. Jones, K. D. Bloch, and W. M. Zapol 5-Lipoxygenase Deficiency Prevents Respiratory Failure during Ventilator-induced Lung Injury Am. J. Respir. Crit. Care Med., August 1, 2005; 172(3): 334 - 343. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Liu, O. V. Evgenov, and F. Ichinose NOS3 deficiency augments hypoxic pulmonary vasoconstriction and enhances systemic oxygenation during one-lung ventilation in mice J Appl Physiol, February 1, 2005; 98(2): 748 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Grichnik and T. A. D'Amico Acute Lung Injury and Acute Respiratory Distress Syndrome After Pulmonary Resection Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2004; 8(4): 317 - 334. [Abstract] [PDF] |
||||
![]() |
F. Ichinose, R. Hataishi, J. C. Wu, N. Kawai, A. C. T. Rodrigues, C. Mallari, J. M. Post, J. F. Parkinson, M. H. Picard, K. D. Bloch, et al. A selective inducible NOS dimerization inhibitor prevents systemic, cardiac, and pulmonary hemodynamic dysfunction in endotoxemic mice Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2524 - H2530. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |